SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029987
Filing Date
2019-08-07
Accepted
2019-08-07 15:37:51
Documents
88
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-10q_20190630.htm 10-Q 2367528
2 EX-10.4 eypt-ex104_247.htm EX-10.4 88264
3 EX-10.5 eypt-ex105_518.htm EX-10.5 114981
4 EX-31.1 eypt-ex311_9.htm EX-31.1 15717
5 EX-31.2 eypt-ex312_8.htm EX-31.2 15666
6 EX-32.1 eypt-ex321_6.htm EX-32.1 6800
7 EX-32.2 eypt-ex322_7.htm EX-32.2 6715
8 GRAPHIC g0n3btqsdsjz000001.jpg GRAPHIC 3354
  Complete submission text file 0001564590-19-029987.txt   9752957

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT eypt-20190630.xml EX-101.INS 2047060
10 XBRL TAXONOMY EXTENSION SCHEMA eypt-20190630.xsd EX-101.SCH 90159
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20190630_cal.xml EX-101.CAL 50989
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20190630_def.xml EX-101.DEF 355874
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20190630_lab.xml EX-101.LAB 607086
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20190630_pre.xml EX-101.PRE 520607
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 191005249
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10